KORU Medical Systems, Inc. KRMD
3.89 USD +0.73 (+23.10%)
At closeNov 11, 2026, 7:06 PM EST
3.77 -0.12 -3.08%
After hours · Nov 11, 7:06 PM ET
3.30 Day range 3.97
2.93 52-week range 6.52
- YTD
- -33.05%
- 1 year
- +4.29%
News
benzinga.com Piper Sandler Reiterates Neutral on KORU Medical Systems, Lowers Price Target to $4.5 Piper Sandler analyst Jason Bednar reiterates KORU Medical Systems (NASDAQ:KRMD) with a Neutral and lowers the price target from $5 to $4.5.
seekingalpha.com KORU Medical Systems, Inc. (KRMD) Q3 2026 Earnings Call Transcript KORU Medical Systems, Inc. (KRMD) Q3 2026 Earnings Call Transcript
marketbeat.com What KORU Medical Systems (KRMD) Said on Its Q3 Earnings Call KORU Medical Systems NASDAQ: KRMD raised the lower end of its 2026 revenue and gross margin guidance after reporting third-quarter revenue growth of 11%, a second consecutive quarter of positive net…
benzinga.com CORRECTION: KORU Medical Systems Q3 Adj. EPS $0.02 Beats $(0.02) Estimate, Sales $11.567M Beat $11.327M Estimate KORU Medical Systems (NASDAQ:KRMD) reported quarterly earnings of $0.02 per share which beat the analyst consensus estimate of $(0.02) by 200 percent. The company reported quarterly sales of $11.567…
benzinga.com KORU Medical Systems Q3 2026 Earnings Call Transcript KORU Medical Systems (NASDAQ:KRMD) reported third-quarter financial results on Tuesday. The transcript from the company’s third-quarter earnings call has been provided below.Benzinga APIs provide…
benzinga.com KORU Medical Systems Raises FY2026 Sales Guidance from $47.500M-$48.500M to $48.000M-$48.500M vs $48.030M Est KORU Medical Systems (NASDAQ:KRMD) raises FY2026 sales outlook from $47.500 million-$48.500 million to $48.000 million-$48.500 million vs $48.030 million estimate.
benzinga.com KORU Medical Systems Q3 Adj. EPS $0.02 Beats $(0.02) Estimate, Sales $10.402M Miss $11.327M Estimate KORU Medical Systems (NASDAQ:KRMD) reported quarterly earnings of $0.02 per share which beat the analyst consensus estimate of $(0.02) by 200 percent. The company reported quarterly sales of $10.402…
businesswire.com KORU Medical Systems Announces Third Quarter 2026 Results Including Second Consecutive Quarter of Positive Net Income and Adjusted EBITDA MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and…
businesswire.com KORU Medical Systems to Report Third Quarter 2026 Financial Results on November 10, 2026 MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on development, manufacturing, and…
defenseworld.net Reviewing Organigram Global (NASDAQ:OGI) & KORU Medical Systems (NASDAQ:KRMD) KORU Medical Systems (NASDAQ: KRMD - Get Free Report) and Organigram Global (NASDAQ: OGI - Get Free Report) are both small-cap healthcare companies, but which is the better business? We will compare…
seekingalpha.com KORU Medical Systems, Inc. (KRMD) Q2 2026 Earnings Call Transcript KORU Medical Systems, Inc. (KRMD) Q2 2026 Earnings Call Transcript
marketbeat.com KORU Medical Systems Q2 Earnings Call Highlights KORU Medical Systems NASDAQ: KRMD reported second-quarter revenue of $12 million, up 18% from a year earlier, as domestic patient starts, market-share gains and international demand supported growth.…
zacks.com KORU Medical Systems, Inc. (KRMD) Q2 Earnings and Revenues Beat Estimates KORU Medical Systems, Inc. (KRMD) came out with quarterly earnings of $0.01 per share, beating the Zacks Consensus Estimate of a loss of $0.02 per share. This compares to break-even earnings per…- benzinga.com Koru Medical Systems Withdraws 510(K) Application For FreedomEDGE With Phesgo In U.S. To Focus On Alternative Higher Volume Molecules "Looking ahead for the remainder of 2026, we expect our international core growth to moderate as we navigate regional launch dynamics in specific European markets converting to pre-filled syringes.…
- benzinga.com KORU Medical Systems Narrows FY2026 Sales Guidance from $47.500M-$50.000M to $47.500M-$48.500M vs $48.688M Est KORU Medical Systems (NASDAQ:KRMD) narrows FY2026 sales outlook from $47.500 million-$50.000 million to $47.500 million-$48.500 million vs $48.688 million estimate.
benzinga.com KORU Medical Systems Q2 Adj. EPS $0.02 Beats $(0.02) Estimate, Sales $12.045M Beat $11.609M Estimate KORU Medical Systems (NASDAQ:KRMD) reported quarterly earnings of $0.02 per share which beat the analyst consensus estimate of $(0.02) by 200 percent. This is a 100 percent increase over earnings of…
businesswire.com KORU Medical Systems Announces Second Quarter 2026 Results and Updates Full Year 2026 Guidance MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and…
businesswire.com KORU Medical Systems to Participate in the Canaccord Genuity 46th Annual Growth Conference MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on development, manufacturing, and…
businesswire.com Kaskela Law LLC Announces Investigation of KORU Medical Systems, Inc. (KRMD) and Encourages Long-Term KRMD Shareholders to Contact the Firm PHILADELPHIA--(BUSINESS WIRE)--Kaskela Law is investigating KORU Medical Systems, Inc. (Nasdaq: KRMD) (“KORU”) on behalf of the company's current shareholders.The investigation seeks to determine…
businesswire.com KORU Medical Systems to Report Second Quarter 2026 Financial Results on August 5, 2026 MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on development, manufacturing, and…- benzinga.com KORU Medical Systems Presents Data Titled 'Reducing Ergonomic Strain During Subcutaneous Monoclonal Antibody Administration' At Oncology Nursing Society Congress KORU Medical Systems, Inc. (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on innovative and patient-centric large volume subcutaneous infusion…
businesswire.com KORU Medical Systems Presents Real World Data on the Benefits of the FreedomEDGE Syringe Infusion System in Infusion Clinics at the 51st Annual Oncology Nursing Society Congress MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on innovative and patient-centric large volume…
seekingalpha.com KORU Medical Systems, Inc. (KRMD) Q1 2026 Earnings Call Transcript KORU Medical Systems, Inc. (KRMD) Q1 2026 Earnings Call Transcript
zacks.com KORU Medical Systems, Inc. (KRMD) Reports Q1 Loss, Tops Revenue Estimates KORU Medical Systems, Inc. (KRMD) came out with a quarterly loss of $0.02 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.03 per share a year ago.
benzinga.com Earnings Scheduled For May 6, 2026 
businesswire.com KORU Medical Systems Announces First Quarter 2026 Results MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and…
businesswire.com KORU Medical Systems to Report First Quarter 2026 Financial Results on May 6, 2026 MAHWAH, NJ--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on development, manufacturing, and…
defenseworld.net KORU Medical Systems, Inc. $KRMD Shares Bought by Acuitas Investments LLC Acuitas Investments LLC grew its holdings in KORU Medical Systems, Inc. (NASDAQ: KRMD) by 89.6% during the third quarter, according to the company in its most recent filing with the Securities and…
zacks.com KORU Medical Secures EU MDR Certification for Freedom60 Infusion Pump KRMD secures EU MDR certification for its Freedom60 Infusion Pump, opening broader EU access and boosting adoption of patient-friendly home infusion solutions.
businesswire.com KORU Medical Systems Announces EU MDR Certification for the Freedom60® Infusion Pump With Prefilled Syringe Compatibility MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems, Inc. (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on the development, manufacturing, and…- benzinga.com Earnings Scheduled For March 12, 2026
benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session - benzinga.com Earnings Scheduled For November 12, 2025
- benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session
- benzinga.com Earnings Scheduled For August 6, 2025
benzinga.com Earnings Scheduled For May 7, 2025 - benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session
benzinga.com Earnings Scheduled For March 12, 2025 - benzinga.com Earnings Scheduled For November 13, 2024
- benzinga.com Earnings Scheduled For March 13, 2024 Companies Reporting Before The Bell • Sangamo Therapeutics (NASDAQ:SGMO) is likely to report quarterly loss at $0.26 per share on revenue of $8.10 million.
- benzinga.com Earnings Scheduled For November 8, 2023 Companies Reporting Before The Bell • Flex LNG (NYSE:FLNG) is estimated to report earnings for its third quarter.
benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2023 
benzinga.com Earnings Scheduled For August 9, 2023 Companies Reporting Before The Bell • Sony Group (NYSE:SONY) is estimated to report quarterly earnings at $0.96 per share on revenue of $18.11 billion.- benzinga.com Earnings Scheduled For May 4, 2023 Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is estimated to report quarterly loss at $1.83 per share on revenue of $104.21 million.
- benzinga.com Earnings Scheduled For March 8, 2023 Companies Reporting Before The Bell • Daktronics (NASDAQ:DAKT) is expected to report quarterly earnings at $0.00 per share on revenue of $164.68 million.
- benzinga.com Earnings Scheduled For November 9, 2022 Companies Reporting Before The Bell • GCM Grosvenor (NASDAQ:GCMG) is likely to report quarterly earnings at $0.11 per share on revenue of $103.46 million.
- benzinga.com Earnings Scheduled For August 3, 2022 Companies Reporting Before The Bell • Fresh Del Monte Produce (NYSE:FDP) is likely to report quarterly earnings at $0.79 per share on revenue of $1.15 billion.
- benzinga.com Stocks That Hit 52-Week Lows On Wednesday Wednesday's session saw 269 companies set new 52-week lows.
- benzinga.com Stocks That Hit 52-Week Lows On Monday On Monday, 198 companies reached new 52-week lows.
- benzinga.com Earnings Scheduled For May 4, 2022 Companies Reporting Before The Bell • Seres Therapeutics (NASDAQ:MCRB) is estimated to report quarterly loss at $0.52 per share on revenue of $8.48 million.